CinCor Pharma, Inc.
CINC · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $136,606 | $26,078 | $11,484 |
| Short-Term Investments | $0 | $0 | $0 |
| Receivables | $0 | $0 | $8 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $4,501 | $0 | $0 |
| Total Curr. Assets | $141,107 | $26,800 | $11,924 |
| Property Plant & Equip (Net) | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $141,107 | $26,800 | $11,924 |
| Liabilities | – | – | – |
| Payables | $642 | $3,666 | $780 |
| Short-Term Debt | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $15,907 | $3,225 | $943 |
| Total Curr. Liab. | $16,549 | $6,891 | $1,723 |
| LT Debt | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 |
| Total NC Liab. | $188,274 | $47,173 | $15,183 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 |
| Total Liabilities | $204,824 | $54,065 | $16,906 |
| Equity | – | – | – |
| Pref Stock | $47,173 | $0 | $0 |
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$77,703 | -$27,334 | -$5,035 |
| AOCI | -$47,173 | $0 | $0 |
| Other Equity | $61,159 | $69 | $53 |
| Total Equity | -$63,717 | -$27,265 | -$4,982 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $141,107 | $26,800 | $11,924 |
| Net Debt | -$136,606 | -$26,078 | -$11,484 |